Liu H - Search Results

1

Compound 48, a novel dual PPAR alpha/gamma ligand, inhibits the growth of human CML cell lines and enhances the anticancer-effects of imatinib.

Bertz J, Zang C, Liu H, Wächter M, Possinger K, Koeffler HP, Elstner E. Bertz J, et al. Among authors: liu h. Leuk Res. 2009 May;33(5):686-92. doi: 10.1016/j.leukres.2008.11.023. Epub 2009 Jan 7. Leuk Res. 2009. PMID: 19131110

2

A novel PPAR alpha/gamma dual agonist inhibits cell growth and induces apoptosis in human glioblastoma T98G cells.

Liu DC, Zang CB, Liu HY, Possinger K, Fan SG, Elstner E. Liu DC, et al. Acta Pharmacol Sin. 2004 Oct;25(10):1312-9. Acta Pharmacol Sin. 2004. PMID: 15456533 Free article.

3

Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.

Zang C, Liu H, Posch MG, Waechter M, Facklam M, Fenner MH, Ruthardt M, Possinger K, Phillip Koeffler H, Elstner E. Zang C, et al. Among authors: liu h. Leuk Res. 2004 Apr;28(4):387-97. doi: 10.1016/j.leukres.2003.07.005. Leuk Res. 2004. PMID: 15109539

4

Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARalpha/gamma ligand TZD18.

Liu H, Zang C, Fenner MH, Liu D, Possinger K, Koeffler HP, Elstner E. Liu H, et al. Among authors: liu d. Blood. 2006 May 1;107(9):3683-92. doi: 10.1182/blood-2005-05-2103. Epub 2006 Jan 10. Blood. 2006. PMID: 16403907 Free article.

5

Dual PPARalpha/gamma ligand TZD18 either alone or in combination with imatinib inhibits proliferation and induces apoptosis of human CML cell lines.

Zang C, Liu H, Waechter M, Eucker J, Bertz J, Possinger K, Koeffler HP, Elstner E. Zang C, et al. Among authors: liu h. Cell Cycle. 2006 Oct;5(19):2237-43. doi: 10.4161/cc.5.19.3259. Epub 2006 Oct 1. Cell Cycle. 2006. PMID: 17102607

6

Induction of endoplasmic reticulum stress response by TZD18, a novel dual ligand for peroxisome proliferator-activated receptor alpha/gamma, in human breast cancer cells.

Zang C, Liu H, Bertz J, Possinger K, Koeffler HP, Elstner E, Eucker J. Zang C, et al. Among authors: liu h. Mol Cancer Ther. 2009 Aug;8(8):2296-307. doi: 10.1158/1535-7163.MCT-09-0347. Epub 2009 Aug 11. Mol Cancer Ther. 2009. PMID: 19671747

7

Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas.

Zang C, Wächter M, Liu H, Posch MG, Fenner MH, Stadelmann C, von Deimling A, Possinger K, Black KL, Koeffler HP, Elstner E. Zang C, et al. Among authors: liu h. J Neurooncol. 2003 Nov;65(2):107-18. doi: 10.1023/b:neon.0000003728.80052.a8. J Neurooncol. 2003. PMID: 14686729

8

Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.

Liu H, Zang C, Emde A, Planas-Silva MD, Rosche M, Kühnl A, Schulz CO, Elstner E, Possinger K, Eucker J. Liu H, et al. Eur J Pharmacol. 2008 Sep 4;591(1-3):43-51. doi: 10.1016/j.ejphar.2008.06.026. Epub 2008 Jun 12. Eur J Pharmacol. 2008. PMID: 18588872

9

The mTOR inhibitor RAD001 sensitizes tumor cells to the cytotoxic effect of carboplatin in breast cancer in vitro.

Liu H, Zang C, Schefe JH, Schwarzlose-Schwarck S, Regierer AC, Elstner E, Schulz CO, Scholz C, Possinger K, Eucker J. Liu H, et al. Anticancer Res. 2011 Sep;31(9):2713-22. Anticancer Res. 2011. PMID: 21868512

10

Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.

Liu H, Scholz C, Zang C, Schefe JH, Habbel P, Regierer AC, Schulz CO, Possinger K, Eucker J. Liu H, et al. Anticancer Res. 2012 May;32(5):1627-37. Anticancer Res. 2012. PMID: 22593441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96,947 results

Search Page

Filters